This steely new language was a win in America’s long quest to get its allies to show more solidarity with Taiwan. Yet in the ...

Arrowhead Pharmaceuticals recently received the FDA NDA acceptance for Plozasiran. Read why I believe ARWR stock could be a ...

Read Hexaware Technologies IPO Review and Analysis on The Economic Times. Find out Hexaware Technologies IPO Issue Price, Subscription Dates and Status, Hexaware Technologies IPO Listing Date and more ...

Bank Nifty Today Live Updates on February 7, 2025: At 16:45 Bank Nifty was trading at 50158.85 (-0.44%). Today Bank Nifty has ...

IPO - Read IPO Review and Analysis on The Economic Times. Find out IPO Issue Price, Subscription Dates and Status, IPO Listing Date and more.

Sionna late Thursday said it is selling nearly 10.6 million shares at $18 apiece in the IPO, compared with prior plans to offer about 8.82 million shares at between $16 and $18 each. The Waltham, Mass ...

Cystic-fibrosis-focused Sionna Therapeutics is joining the Nasdaq this morning with an upsized public offering, while obesity ...

Clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis—Sionna Therapeutics (SION) priced its upsized initial public offering of ...

The gross proceeds from the initial public offering are expected to be approximately $191 million, before deducting underwriting discounts and commissions and other offering expenses, and excluding ...

The biotech is evaluating several cystic fibrosis medicines that could either work alongside Vertex’s top-selling Trikafta or ...

US private equity firm Riverwood Capital is buying Quicklizard for NIS 186 million, reflecting a 30% premium on yesterday's ...

Doosan Skoda Power AS jumped 16% on its first trading day in Prague after the producer of steam turbines completed an initial ...